Valuation: Nephros, Inc.

Market Cap 39.41M 34.57M 32.01M 29.46M 55.72M 3.77B 56.8M 382M 150M 1.85B 148M 145M 6.4B P/E 2026 *
80.7x
P/E 2027 * 36.3x
Enterprise Value 39.41M 34.57M 32.01M 29.46M 55.72M 3.77B 56.8M 382M 150M 1.85B 148M 145M 6.4B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.7x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 2023-05-04
Director of Finance/CFO 60 2023-10-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 2007-09-18
Director/Board Member 54 2018-08-09
Director/Board Member 58 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 39.41M
-3.44%-6.75% - - 18.35B
+0.04%-2.29%+27.09%+42.94% 10.34B
-2.07%+1.51%+169.76%+515.79% 4.88B
-4.09%-5.36%+64.79%+287.31% 4.53B
-11.98%-13.45%+128.93%+131.92% 1.93B
-6.08%-11.46% - - 1.34B
-7.91%-14.30%+154.77%+147.85% 1.05B
+1.53%-3.38%-19.77%-9.73% 919M
-8.98%-23.07%+38.97%+23.63% 880M
Average -4.30%-5.07%+80.65%+162.82% 4.91B
Weighted average by Cap. -3.10%-1.76%+74.60%+191.00%

Financials

2026 *2027 *
Net sales 21.08M 18.49M 17.13M 15.76M 29.81M 2.02B 30.39M 204M 80.06M 991M 79.17M 77.44M 3.42B 23.13M 20.28M 18.79M 17.29M 32.7M 2.21B 33.33M 224M 87.82M 1.09B 86.84M 84.94M 3.75B
Net income 517K 453K 420K 386K 731K 49.48M 745K 5.01M 1.96M 24.3M 1.94M 1.9M 83.92M 1.19M 1.05M 968K 891K 1.69M 114M 1.72M 11.54M 4.53M 56.03M 4.48M 4.38M 193M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-